Literature DB >> 23585531

Somatic hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse.

Martin Wartenberg1, Peter Vasil, Christian Meyer zum Bueschenfelde, German Ott, Andreas Rosenwald, Falko Fend, Marcus Kremer.   

Abstract

In follicular lymphoma, somatic hypermutation of the immunoglobulin heavy chain genes facilitates the identification of different lymphoma cell clones, and the construction of genealogical trees. To investigate the dissemination of lymphoma cells, and the role of bone marrow in disease progression, we simultaneously analyzed the somatic hypermutation patterns of lymph node and bone marrow specimens taken from three patients at onset and relapse of their disease. Immunoglobulin heavy chain genes were amplified by polymerase chain reaction, cloned and sequenced. Mutational pedigrees were constructed in a hierarchical order. When direct transition of one mutation pattern into that of a successor clones was not feasible, hypothetical predecessor clones were created, and a probability measurement calculation was introduced. Eighty-five sequenced clones were generated. The average mutation rates were 13.45% for the lymph node specimens, and 9.78% for the bone marrow ones. Forty-two hypothetical predecessor clones were introduced into inter-compartment pedigrees. The genealogical trees showed that early lymphoma clones with a low mutational load quickly migrate from lymph nodes into the bone marrow. Bi-directional lymphoma cell migration was detectable between the two compartments. In one case of follicular lymphoma, a clone identical to the initial lymph node clone was detected 2 years later in the bone marrow. The newly introduced algorithm allows the evaluation of both time and direction of follicular lymphoma cell migration. We found evidence that follicular lymphoma originates in the lymph node, and infiltrates the bone marrow early in the course of the disease. Moreover, inter-compartment migration between lymph nodes and bone marrow occurs in both directions.

Entities:  

Mesh:

Year:  2013        PMID: 23585531      PMCID: PMC3762101          DOI: 10.3324/haematol.2012.074252

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  47 in total

1.  The inference of antigen selection on Ig genes.

Authors:  I S Lossos; R Tibshirani; B Narasimhan; R Levy
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

2.  Variable heavy-chain gene analysis of follicular lymphomas: subclone selection rather than clonal evolution over time.

Authors:  W M Aarts; R J Bende; J G Bossenbroek; S T Pals; C J van Noesel
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

Review 3.  Molecular insights into the immunopathogenesis of follicular lymphoma.

Authors:  K Stamatopoulos; C Kosmas; C Belessi; N Stavroyianni; P Kyriazopoulos; T Papadaki
Journal:  Immunol Today       Date:  2000-06

4.  Stromal cell-derived factor-1 as a chemoattractant for follicular center lymphoma B cells.

Authors:  A Corcione; L Ottonello; G Tortolina; P Facchetti; I Airoldi; R Guglielmino; P Dadati; M Truini; S Sozzani; F Dallegri; V Pistoia
Journal:  J Natl Cancer Inst       Date:  2000-04-19       Impact factor: 13.506

5.  Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma.

Authors:  Armin G Jegalian; Franziska C Eberle; Svetlana D Pack; Mariya Mirvis; Mark Raffeld; Stefania Pittaluga; Elaine S Jaffe
Journal:  Blood       Date:  2011-07-18       Impact factor: 22.113

Review 6.  Follicular dendritic cells: beyond the necessity of T-cell help.

Authors:  J G Tew; J Wu; M Fakher; A K Szakal; D Qin
Journal:  Trends Immunol       Date:  2001-07       Impact factor: 16.687

7.  Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.

Authors:  M Muramatsu; K Kinoshita; S Fagarasan; S Yamada; Y Shinkai; T Honjo
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

8.  Tumor cell dissemination in follicular lymphoma.

Authors:  Sabine Oeschger; Andreas Bräuninger; Ralf Küppers; Martin-Leo Hansmann
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

9.  The usefulness of immunohistochemistry in the diagnosis of follicular lymphoma in bone marrow biopsy specimens.

Authors:  Robert B West; Roger A Warnke; Yasodha Natkunam
Journal:  Am J Clin Pathol       Date:  2002-04       Impact factor: 2.493

10.  In situ analysis of the variable heavy chain gene of an IgM/IgG-expressing follicular lymphoma: evidence for interfollicular trafficking of tumor cells.

Authors:  Wilhelmina M Aarts; Richard J Bende; Jan-Willem Vaandrager; Philip M Kluin; Anton W Langerak; Steven T Pals; Carel J M van Noesel
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

View more
  11 in total

1.  DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma.

Authors:  Rada Amin; Frédéric Mourcin; Fabrice Uhel; Céline Pangault; Philippe Ruminy; Loic Dupré; Marion Guirriec; Tony Marchand; Thierry Fest; Thierry Lamy; Karin Tarte
Journal:  Blood       Date:  2015-08-13       Impact factor: 22.113

2.  Origin and migration of follicular lymphoma cells.

Authors:  Philip M Kluin
Journal:  Haematologica       Date:  2013-09       Impact factor: 9.941

3.  Genomic and epigenomic co-evolution in follicular lymphomas.

Authors:  M Loeffler; M Kreuz; A Haake; D Hasenclever; H Trautmann; C Arnold; K Winter; K Koch; W Klapper; R Scholtysik; M Rosolowski; S Hoffmann; O Ammerpohl; M Szczepanowski; D Herrmann; R Küppers; C Pott; R Siebert
Journal:  Leukemia       Date:  2014-07-16       Impact factor: 11.528

Review 4.  From genetics to the clinic: a translational perspective on follicular lymphoma.

Authors:  Sarah Huet; Pierre Sujobert; Gilles Salles
Journal:  Nat Rev Cancer       Date:  2018-02-09       Impact factor: 60.716

5.  Immunohistochemical analysis indicates that the anatomical location of B-cell non-Hodgkin's lymphoma is determined by differentially expressed chemokine receptors, sphingosine-1-phosphate receptors and integrins.

Authors:  Stephen Middle; Sarah E Coupland; Azzam Taktak; Victoria Kidgell; Joseph R Slupsky; Andrew R Pettitt; Kathleen J Till
Journal:  Exp Hematol Oncol       Date:  2015-04-01

6.  Next generation sequencing of the clonal IGH rearrangement detects ongoing mutations and interfollicular trafficking in in situ follicular neoplasia.

Authors:  Perikles Kosmidis; Irina Bonzheim; Claudia Dufke; Sema Colak; Thomas Hentrich; Christopher Schroeder; Peter Bauer; Patrick Adam; Falko Fend
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

7.  Grade I, II and III Follicular Lymphomas Express Ig VH Genes with Different Patterns of Somatic Mutation.

Authors:  Balázs Csernus; Botond Timár; Zsolt Fülöp; András Matolcsy
Journal:  Pathol Oncol Res       Date:  2020-07-23       Impact factor: 3.201

8.  Dramatic increase in gene mutational burden after transformation of follicular lymphoma into TdT+ B-lymphoblastic leukemia/lymphoma.

Authors:  Jonathan P Belman; Wenzhao Meng; Hong Yi Wang; Jie Li; Honore T Strauser; Aaron M Rosenfeld; Qian Zhang; Eline T Luning Prak; Mariusz Wasik
Journal:  Cold Spring Harb Mol Case Stud       Date:  2020-02-03

9.  Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma.

Authors:  Sarah Haebe; Tanaya Shree; Anuja Sathe; Grady Day; Debra K Czerwinski; Susan M Grimes; HoJoon Lee; Michael S Binkley; Steven R Long; Brock Martin; Hanlee P Ji; Ronald Levy
Journal:  Blood       Date:  2021-05-27       Impact factor: 25.476

10.  Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.

Authors:  Alina M Bischin; Russell Dorer; David M Aboulafia
Journal:  Clin Med Insights Blood Disord       Date:  2017-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.